Evaluation of Longitudinal Ventricular Function with Tissue Doppler Echocardiography in Children Treated with Anthracyclines

Journal of the American Society of Echocardiography

Volumn 20, Issue 5, 2007, Pages 492-497

  Stapleton, Gary E ^a   Stapleton, Stacie L ^a   Martinez, Ana ^a   Ayres, Nancy A ^a   Kovalchin, John P ^a   Bezold, Louis I ^b   Pignatelli, Ricardo ^a   Eidem, Benjamin W ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CARDIOTOXICITY; CHILDHOOD CANCER; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; SCHOOL CHILD; UNITED STATES;

ADOLESCENT; ADULT; ANTHRACYCLINES; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MYOCARDIAL CONTRACTION; NEUROBLASTOMA; PROGNOSIS; RETROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 34247639959     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2006.10.011     Document Type: Article

References (19)

1. Sorenson K., Levitt G.A., Bull C., Dorup I., and Sullivan I.D. Late anthracycline cardiotoxicity after childhood cancer. Cancer 97 (2003) 1991-1998
2. Lipshultz S.E., Rifai N., Dalton V.M., et al. The effect of Dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med 351 (2004) 145-153
3. Krischer J.P., Epstein S., Cuthbertson D.D., et al. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the pediatric oncology group experience. J Clin Oncol 15 (1997) 1544-1552
4. Singal P.K., and Iliskovic N. Current concepts: doxorubicin-induced cardiomyopathy. N Engl J Med 339 (1998) 900-905
5. Eidem B.W., Sapp B.G., Suarez C.R., and Cetta F. Usefulness of the myocardial performance index for early detection of anthracycline-induced cardiotoxicity in children. Am J Cardiol 87 (2001) 1120-1122
6. Kapusta L., Groot-Loonen J., Thijssen J.M., Degraaf R., and Daniels O. Regional cardiac wall motion abnormalities during and shortly after anthracycline therapy. Med Pediatr Oncol 41 (2003) 426-435
7. Eidem B.W., Tei C., O'Leary P.W., Cetta F., and Seward J.B. Non-geometric quantitative assessment of right and left ventricular function: myocardial performance index in normal children and patients with Ebstein anomaly. J Am Soc Echocardiogr 11 (1998) 849-856
8. Eidem B.W., McMahon C.J., Cohen R.R., et al. Impact of cardiac growth on Doppler tissue imaging velocities: a study in normal children. J Am Soc Echocardiogr 17 (2004) 212-221
9. Kremer C.M., and Caron H.N. Anthracycline cardiotoxicity in children. N Engl J Med 351 (2004) 120-121
10. Dorup I., Levitt G., Sullivan I., and Sorensen K. Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic dysfunction. Heart 90 (2004) 1214-1216
11. Ocal B., Oguz D., Karademir S., et al. Myocardial performance index combining systolic and diastolic myocardial performance in doxorubicin-treated patients and its correlation to conventional echo/Doppler indices. Pediatr Cardiol 23 (2002) 522-527
12. Bu'Lock F.A., Mott M.G., Oakhill A., and Martin R.P. Left ventricular diastolic filling patterns associated with progressive anthracycline-induced myocardial damage: a prospective study. Pediatr Cardiol 20 (1999) 252-263
13. Mason J.W., Bristow M.R., Billingham M.E., and Daniels J.R. Invasive and non-invasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy. Cancer Treat Rep 62 (1978) 857-864
14. Arola O.J., Saraste A., Pulkki K., Kallojoki M., Parvinen M., and Voipio-Pulkki L.M. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res 60 (2000) 1789-1792
15. Tassan-Mangina S., Codorean D., Metivier M., et al. Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study. Eur J Echocardiogr 7 (2006) 141-146
16. Friedberg M.K., and Rosenthal D.N. New developments in echocardiographic methods to assess right ventricular function in congenital heart disease. Curr Opin Cardiol 20 (2005) 84-88
17. Urheim S., Edvardsen T., Torp H., Angelsen B., and Smiseth O.A. Myocardial strain by Doppler echocardiography-validation of a new method to quantify regional myocardial function. Circulation 102 (2000) 1158-1164
18. Takenaka K., Kuwada Y., Sonada M., et al. Anthracycline-induced cardiomyopathies evaluated by tissue Doppler tracking system and strain rate imaging. J Cardiol 37 (2001) 129-132
19. Eidem B.W., McMahon C.J., Ayres N.A., et al. Impact of chronic left ventricular preload and afterload on Doppler tissue imaging velocities: a study in congenital heart disease. J Am Soc Echocardiogr 18 (2005) 830-838